CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Take proper precautions and seek timely treatment!
Marks the World Head & Neck Cancer Day at the OCTF Conference
KEYTRUDA plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
First of its kind screening for Glaucoma at grass root level over 10k screened already
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
The VITA-FAST tokens have been met with overwhelming interest
Subscribe To Our Newsletter & Stay Updated
